Comprehensive Physiology and Pathophysiology of Pain: Nociception, Pathways, and Modulation

Overview of the Pain Pathway and Nociception

  • Pain is described as a nebulous and multifactorial experience.

  • The pain pathway is comprised of four primary processes (TTMP):

    • Transduction

    • Transmission

    • Modulation

    • Perception

  • The pathway involves three orders of neurons:

    • First Order Neurons

    • Second Order Neurons

    • Third Order Neurons

Nociceptors and the Process of Transduction

  • Nociceptors are free nerve endings that respond specifically to noxious stimuli.

  • They respond to thermal (heat), mechanical, or chemical tissue damage.

  • They possess a high threshold for activation, meaning they require a strong stimulus to fire.

  • The underlying mechanism of tissue injury and nociceptor activation involves:

    • Tissue injury activates immune cells at the site, including Neutrophils, Mast cells, and Macrophages.

    • These cells release inflammatory mediators.

    • These chemicals sensitize the nociceptor, making it more excitable and easier to fire.

  • Metaphor/Analogy for Sensitization: Capsaicin activates TRPV1TRPV1 on nerve endings, which increases neuron expression and excitability.

  • Step-by-Step Pathway of Transduction and Transmission:

    • 1. Tissue Injury occurs.

    • 2. Inflammatory mediators are released.

    • 3. Nociceptors are activated.

    • 4. An Action Potential (AP) is generated.

    • 5. The signal travels to the dorsal horn of the spinal cord.

    • 6. The signal ascends via the spinothalamic tract.

    • 7. The brain perceives the pain.

Specific Types of Nociceptors

  • Mechanoreceptors: These respond specifically to mechanical injury, such as a pinch or a pinprick.

  • Silent Nociceptors:

    • These remain inactive under normal conditions.

    • They only become active during states of inflammation.

    • Clinical examples include appendicitis, arthritis, and Irritable Bowel Syndrome (IBS).

  • Polymodal Mechanoheat Nociceptors:

    • Description: The most prevalent and common type of nociceptor.

    • Characteristics: These are slow to adapt to strong pressure.

    • Responsiveness: They respond to heat sensitization, chemical irritants (e.g., histamine, prostaglandins), excessive pressure, temperature extremes, and various noxious substances.

  • Visceral Nociceptors:

    • Autonomic Involvement:

      • Visceral pain fibers travel alongside autonomic nerves.

      • Primary afferent neurons travel with efferent autonomic nerve fibers.

    • Sympathetic Nervous System (SNS) Integration (Thoracolumbar):

      • Visceral neurons enter the spinal cord between segment T1T1 and L2L2.

      • They interact with the SNS; sympathetic preganglia emerge from T1T1 to L2L2.

      • Substance P sends collateral fibers to the paravertebral sympathetic ganglia.

      • High-intensity stimulation of the viscera directs post-ganglionic sympathetic discharge.

      • When visceral pain is intense, the release of Substance P branches into paravertebral sympathetic ganglia, triggering SNS symptoms such as increased heart rate (HR\uparrow HR), increased blood pressure (BP\uparrow BP), and pallor.

    • Parasympathetic Nervous System (PNS) Integration (Craniosacral):

      • Sensory fibers for the esophagus, larynx, and trachea travel with the vagus nerve.

      • Fibers for the bladder, prostate, rectum, cervix, urethra, and genitalia travel via the S2S2 to S4S4 nerve roots.

    • Clinical Presentation of Visceral Pain:

      • Nociceptors respond to disease and abnormal functioning of internal organs or their coverings (parietal pleura, pericardium, peritoneum).

      • Visceral organs are generally insensitive to standard surgical stimuli like cutting, burning, or crushing.

      • Silent nociceptors are typical in organs (e.g., appendicitis).

      • Visceral polymodal nociceptors respond to smooth muscle spasms (biliary or renal colic), ischemia, and distention of hollow structures.

Nociceptive Nerve Fibers

  • Primary afferent neurons are comprised of peripheral nerve fibers classified by size and function:

    • AδA\delta (A-delta) Fibers: Conduct signals that are fast, sharp, and well-localized. This is referred to as "first pain."

    • CC Fibers: Conduct signals that are dull and poorly localized.

Neuroanatomy and Function of the Dorsal Horn

  • Pathway Layout: Nociceptor \rightarrow Dorsal root ganglion \rightarrow Dorsal horn \rightarrow Brain.

  • The dorsal horn serves as the spinal cord’s central pain processing station.

  • Internal Organization:

    • AδA\delta and CC fibers enter the dorsal horn and synapse.

    • The marginal layer (lamina I) relays pain directly.

    • Lamina II (Substantia Gelatinosa):

      • This area amplifies or inhibits pain signals.

      • It is the primary site where endorphins and enkephalins function.

      • Major site of action for opioid medications.

      • Plays a major role in processing/modulating input from cutaneous nociceptors.

    • Laminae III to VI: These layers mix information regarding touch and pain.

  • Neuron Synapses within the Dorsal Horn:

    • First-order neurons synapse with four potential targets: Second-order neurons, Interneurons, Sympathetic neurons, and Ventral motor neurons.

  • Role of Interneurons: Essential for the integration and modulation (both excitation and inhibition) of incoming nociceptive information.

  • Laminae Structure: Spinal cord gray matter is divided into 10 total laminae; the dorsal horn is composed of the first 6.

Second-Order Neurons and the Spinothalamic Tract

  • Second-Order Neurons:

    • Axons of second-order neurons cross the midline of the spinal cord (decussate).

    • They ascend contralaterally through the spinothalamic tract to reach the thalamus.

    • They synapse with third-order neurons in the thalamic nuclei.

  • Wide Dynamic Range (WDR) Neurons:

    • These are the most prevalent cell type in the dorsal horn.

    • They conduct both noxious and non-noxious signals from AβA\beta, AδA\delta, and CC fibers.

    • They are the major target for "wind up," a primary mechanism in chronic pain.

  • The Spinothalamic Tract (The "Pain Highway"):

    • This is the major ascending pain pathway.

    • Integration with Systems:

      • SNS Integration: Synapses via the intermediolateral column lead to sympathetically mediated vasoconstriction reflexes and catecholamine release.

      • Motor System Integration: Dorsal horn sensory neurons synapse with anterior horn motor neurons, causing reflex muscle activity associated with pain.

  • Endpoints of the Spinothalamic Tract (VMPR):

    • V: Ventral Posterolateral Nucleus of the Thalamus (VPLVPL). Function: Processes pain details (location, intensity, duration).

    • M: Medial Thalamus. Function: Processes the emotional components of pain ("Emotional pain").

    • P: Periaqueductal Gray (PAG). Function: Serves as a link between ascending and descending pathways ("Pain control center").

    • R: Reticular Activating System (RAS). Function: Governs arousal and wakefulness response ("Body reacts to pain").

Third-Order Neurons and Perception

  • Second-order neurons synapse with third-order neurons specifically in the thalamus.

  • The thalamus acts as the relay station for incoming signals to the primary somatosensory cortex.

  • Third-order neurons travel to somatosensory areas 1 and 2 located in:

    • The postcentral gyrus of the parietal cortex.

    • The superior wall of the Sylvian fissure.

  • Perception is defined as the discrimination of specific sensory experiences and the localization of pain.

Modulation of Pain: Principles and Neurotransmitters

  • Definition: Modulation is the process that can either inhibit or facilitate pain pathways.

  • Locations: Occurs peripherally at nociceptors and centrally in the spinal cord and supraspinal structures.

  • Mediators: Influenced by neurotransmitters and inflammatory factors.

  • Excitatory Neurotransmitters (Facilitate Pain / "+"):

    • Substance P (Receptor: Neurokinin-1 / NK1NK-1)

    • Calcitonin gene-related peptide (CGRP)

    • Glutamate (Receptors: NMDANMDA, AMPAAMPA, kainate, quisqualate)

    • Aspartate (Receptors: NMDANMDA, AMPAAMPA, kainate, quisqualate)

    • Adenosine triphosphate (ATP) (Receptors: P1P1, P2P2)

  • Inhibitory Neurotransmitters (Inhibit Pain / "-"):

    • Somatostatin

    • Acetylcholine (Muscarinic receptors)

    • Enkephalins and β\beta-Endorphin (Receptors: μ\mu, δ\delta, κ\kappa)

    • Norepinephrine (NENE)

    • Adenosine (A1A_1)

    • Serotonin (5HT15-HT_1, 5HT35-HT_3)

    • γ\gamma-Aminobutyric acid (GABA) (GABAAGABA_A, GABABGABA_B)

    • Glycine

Peripheral Modulation and Sensitization

  • Process: Chemical mediators sensitize nociceptors, increasing responsiveness and lowering firing thresholds.

  • Primary Hyperalgesia: A heightened response to a normally painful stimulus at the site of injury.

  • Pathway Factors:

    • Lowered firing threshold and increased range of stimuli (including non-noxious stimuli).

    • Result of inflammatory mediators and noxious stimuli.

    • Usually self-resolving, but becomes chronic if no resolution occurs within 1-2 months.

  • Key Chemical Mediators:

    • Bradykinin: A peptide released during inflammation; it is algesic (pain-causing) and directly stimulates peripheral nociceptors.

    • Serotonin (5HT5-HT): Released after tissue injury; algesic effects; can potentiate bradykinin-induced pain. It has both excitatory and inhibitory roles.

    • Substance P: Released from first-order neurons at the dorsal horn and peripheral nociceptors. It degranulates histamine from mast cells and 5HT5-HT from platelets. It is a potent vasodilator and leukocyte chemoattractant.

    • Additional Mediators: Protons (H+H^+), Purines, Eicosanoids (Prostaglandins, Thromboxanes, Leukotrienes), Endocannabinoids, Neurotrophins (NGF), and Cytokines (IL1βIL-1\beta, TNFαTNF-\alpha, IL6IL-6, LIFLIF).

Central Modulation and Sensitization Mechanisms

  • Sensitization occurs in the spinal cord and second-order neurons through three primary mechanisms:

    • 1. Wind Up: An activity-dependent progressive increase in neuron response over a train of inputs.

    • 2. Receptor Field Expansion: Dorsal horn neurons increase their receptive fields, causing adjacent neurons to respond to stimuli they previously ignored.

    • 3. Hyperexcitability of flexion reflexes.

  • Step-by-Step Mechanism of "Wind Up":

    • 1. Repetitive discharge of primary afferent nociceptors.

    • 2. Co-release of glutamate and mediators from the dorsal horn.

    • 3. Substance P activates the NK1NK-1 receptor.

    • 4. Summation of potentials removes the Mg2+Mg^{2+} suppression of the NMDANMDA receptor.

    • 5. Activation of the NMDANMDA receptor allows Ca2+Ca^{2+} entry, which induces Nitric Oxide Synthase to form Nitric Oxide (NONO).

    • 6. Excitatory amino acids are released in the spinal cord.

    • Chronic pain is facilitated by the activation of Protein Kinase C (PKCPKC), closure of K+K^+ channels, and cfosc-fos gene expression.

Theories and Systems of Pain Inhibition

  • Gate Theory (Segmental Inhibition):

    • Afferent fibers can inhibit other afferent fibers.

    • Activation of large mechanoreceptor fibers activates an inhibitory interneuron in the dorsal horn.

    • This interneuron causes presynaptic inhibition, "closing the gate" to noxious information by inhibiting WDR neurons and spinothalamic activity.

    • Key neurotransmitters: Glycine and GABA.

  • Supraspinal Inhibition (Descending Pathways):

    • The Periaqueductal Gray (PAG) of the midbrain receives input from higher brain structures and connects to the Rostral Ventromedial Medulla (RVM).

    • Descending inhibitory pathways (composed of Serotonergic and Noradrenergic neurons) travel down to the spinal cord.

    • Endogenous and exogenous opioids inhibit pain via the Substantia Gelatinosa in the dorsal horn.

    • Noradrenergic neurons (NENE) contribute modulation via α2\alpha_2 (alpha-2) receptors.

    • The RVM receives input from serotonin-containing neurons in the Nucleus Raphe Magnus (NRM).